课题基金 / 基金详情

Dissecting the Molecular Basis of the Malaria Parasite-Erythrocyte Tight Junction Complex

Dissecting the Molecular Basis of the Malaria Parasite-Erythrocyte Tight Junction Complex
剖析疟疾寄生虫-红细胞紧密连接复合物的分子基础
批准号:
nhmrc : 637340
负责人:
A/Pr Stuart Ralph
金额:
$36.5万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2010
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2010-01-01 至 2012-12-31

项目摘要

项目成果

A/Pr Stuart Ralph的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The parasites that cause malaria disease must invade the human red blood cell to complete their lifecycle. Invasion requires the formation of a complex interface between parasite and red cell called the Tight Junction. However, this structure's molecular makeup is entirely unknown. Our research will use a combination of state-of-the-art microscopy and genetics to define, for the first time, the junction's organization, providing a critical platform for the development of a malaria vaccine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular basis of artemisinin action and resistance in Plasmodium falciparum
  • 批准号:
    nhmrc : GNT1139884
  • 项目类别:
    Project Grants
  • 资助金额:
    $75.85万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Stuart Ralph
  • 依托单位:
Molecular basis of artemisinin action and resistance in Plasmodium falciparum
  • 批准号:
    nhmrc : 1139884
  • 项目类别:
    Project Grants
  • 资助金额:
    $51.28万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Stuart Ralph
  • 依托单位:
Cell biology of malaria parasites
  • 批准号:
    nhmrc : GNT1062504
  • 项目类别:
    Career Development Fellowships
  • 资助金额:
    $44.78万
  • 财政年份:
    2014
  • 负责人:
    A/Pr Stuart Ralph
  • 依托单位:
Understanding whole cell protein trafficking in Plasmodium parasites
  • 批准号:
    nhmrc : 1062504
  • 项目类别:
    Career Development Fellowships
  • 资助金额:
    $31.11万
  • 财政年份:
    2014
  • 负责人:
    A/Pr Stuart Ralph
  • 依托单位:
国内基金
海外基金
Kidney injury molecular(KIM-1)介导肾小管上皮细胞自噬在糖尿病肾病肾间质纤维化中的作用
  • 批准号:
    81300605
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2013
  • 负责人:
    唐琳
  • 依托单位:
Molecular Plant
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
Molecular Plant